Read more

July 14, 2022
1 min read
Save

Ocular surface altered in subjects with untreated obstructive sleep apnea

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Individuals with moderate/severe obstructive sleep apnea more commonly had floppy eyelid syndrome, shorter tear breakup time and higher ocular redness scores than those with normal/mild OSA, according to a study.

Perspective from Kaitlyn Kolzow, OD, FAAO

Previous research has evaluated systemic disease in those with untreated obstructive sleep apnea (OSA) and “the associations between tear film disorders and OSA, but did not objectively assess the changes of ocular surface in OSA patients,” Pei-Wen Lin, of the division of glaucoma, department of ophthalmology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City, Taiwan, and colleagues wrote in Nature and Science of Sleep.

The researchers sought to evaluate these issues in untreated patients with OSA and normal control subjects and analyze any correlations in depth.

One hundred eighty-one participants underwent polysomnography to determine the occurrence and severity of their OSA; received the Ocular Surface Disease Index (OSDI) questionnaire, ophthalmic exams, measurement of tear meniscus height and noninvasive tear film breakup time testing; and were evaluated for ocular surface redness, endothelial cell density and corneal fluorescein staining.

Floppy eyelid syndrome was found in 11.5% of the control group, 45.3% of the mild OSA group, 45.2% of the moderate OSA group and 60% of the severe OSA group, with significant differences among the groups in tear breakup time and redness scores. No significant differences were seen in the OSDI, tear meniscus height, central corneal thickness, endothelial cell density, Schirmer test or corneal staining.

“If the hypoxia causes ocular surface inflammation and damage, longer duration and greater severity of OSA will result in greater changes of ocular surface,” the researchers said. “Longitudinal evaluations of ocular surface change and tear film performance, including meibomian gland dysfunction and tear osmolarity, can be necessary in patients with OSA.”